HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Resveratrol induces mitochondrial biogenesis in endothelial cells.

Abstract
Pathways that regulate mitochondrial biogenesis are potential therapeutic targets for the amelioration of endothelial dysfunction and vascular disease. Resveratrol was shown to impact mitochondrial function in skeletal muscle and the liver, but its role in mitochondrial biogenesis in endothelial cells remains poorly defined. The present study determined whether resveratrol induces mitochondrial biogenesis in cultured human coronary arterial endothelial cells (CAECs). In CAECs resveratrol increased mitochondrial mass and mitochondrial DNA content, upregulated protein expression of electron transport chain constituents, and induced mitochondrial biogenesis factors (proliferator-activated receptor-coactivator-1alpha, nuclear respiratory factor-1, mitochondrial transcription factor A). Sirtuin 1 (SIRT1) was induced, and endothelial nitric oxide (NO) synthase (eNOS) was upregulated in a SIRT1-dependent manner. Knockdown of SIRT1 (small interfering RNA) or inhibition of NO synthesis prevented resveratrol-induced mitochondrial biogenesis. In aortas of type 2 diabetic (db/db) mice impaired mitochondrial biogenesis was normalized by chronic resveratrol treatment, showing the in vivo relevance of our findings. Resveratrol increases mitochondrial content in endothelial cells via activating SIRT1. We propose that SIRT1, via a pathway that involves the upregulation of eNOS, induces mitochondrial biogenesis. Resveratrol induced mitochondrial biogenesis in the aortas of type 2 diabetic mice, suggesting the potential for new treatment approaches targeting endothelial mitochondria in metabolic diseases.
AuthorsAnna Csiszar, Nazar Labinskyy, John T Pinto, Praveen Ballabh, Hanrui Zhang, Gyorgy Losonczy, Kevin Pearson, Rafael de Cabo, Pal Pacher, Cuihua Zhang, Zoltan Ungvari
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 297 Issue 1 Pg. H13-20 (Jul 2009) ISSN: 1522-1539 [Electronic] United States
PMID19429820 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • DNA, Mitochondrial
  • RNA, Messenger
  • RNA, Small Interfering
  • Stilbenes
  • Nitric Oxide Synthase Type III
  • Sirt1 protein, mouse
  • Sirtuin 1
  • Sirtuins
  • Resveratrol
Topics
  • Animals
  • Antioxidants (pharmacology)
  • Aorta, Thoracic (cytology, drug effects, metabolism)
  • Cells, Cultured
  • DNA, Mitochondrial (biosynthesis, genetics)
  • Diabetes Mellitus, Type 2 (genetics)
  • Electron Transport (drug effects, genetics)
  • Endothelial Cells (drug effects, metabolism, ultrastructure)
  • Endothelium, Vascular (physiology)
  • Enzyme Induction
  • Mice
  • Mitochondria (metabolism)
  • Nitric Oxide Synthase Type III (biosynthesis)
  • RNA, Messenger (biosynthesis, genetics)
  • RNA, Small Interfering (biosynthesis, genetics)
  • Resveratrol
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sirtuin 1
  • Sirtuins (drug effects, genetics)
  • Stilbenes (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: